To make an appointment with NYC urologist and prostate cancer specialist Dr. Christopher Barbieri, please call our office at (212) 746-5562.
For other inquires and additional providers specializing in prostate cancer care at Weill Cornell Medicine in New York City, please call our office at (646) 962-9600.
To make an appointment with Dr. Christopher Barbieri at Weill Cornell Medicine Urology in New York City, please call our office at (212) 746-5562.
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.
Dr. Christopher Barbieri speaks at an US TOO prostate cancer educational seminar at Weill Cornell Medicine to discuss the role of genomics in the identification and treatment of specific subtypes of prostate cancer, precision medicine tactics, as well as emerging therapies.
Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer genomics, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New-York Presbyterian, discusses the implications of SPOP mutations in patients with prostate cancer.
Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.